We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
RETIRED - shielded patient list identification methodology Version 1
- Publication date :
- 24 Mar 2020
This document describes the methodology that has been used to identify patients who meet the high risk criteria for contracting coronavirus (COVID-19), due to their inclusion in one or more of the disease groups as outlined in table 1.
The list of conditions that defined this cohort was signed off by the Chief Medical Officers of the four nations of the UK on 18 March 2020 and is listed in this document.
Published March 2020 Version 1.0
The Chief Medical Officer (CMO) for England, working with the CMOs of the devolved nations and other senior clinicians, commissioned NHS Digital to produce a list of people at “high risk” of complications from COVID-19, who should be shielded for at least 12 weeks.
This list is referred to as the Shielded Patient List (SPL). The “high risk” list was defined as a subset of a wider group of people who may be “at risk”.
Specific advice applies to these groups, currently this advice is:
- “At Risk” – large group (circa 19 million) normally at risk from the flu - should practice strict social distancing
- “At high risk” – a smaller sub-group (circa 1.5 million), defined by CMO – should practice complete social “shielding”
Last edited: 13 June 2020 2:39 pm